Palliative care in Parkinson’s disease and neurodegenerative diseases

Levin O.S.; Bril E.V.; Zimnyakova O.S.; Anikina M.A.; Hasina A.V.; Fedorova N.V.

doi:https://doi.org/10.17116/jnevro20201201025

Close metadata

Recommended articles:

Sleep disorders in patients with Lewy body dementia and Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):81-87

Art and creativity in Parkinson’s disease: the mysterious effects of dopamine. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):13-20

Correlation of motor symptoms and cardiovascular dysfunction in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):59-67

Diagnosis of pathological and adaptive balance changes in Parkinson’s disease to select a rehabilitation program. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):88-94

High-flow nasal cannula therapy in patients with COPD. Journal of Respiratory Medicine. 2025;(2):17-38

Potential and prospects of the astragaloside IV use for age-associated diseases prevention. Russian Journal of Preventive Medicine. 2025;(7):94-99

Effect of uric acid on the progression of Parkinson’s disease: Myth or reality?. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):7-14

Dynamics of permeability of the blood-brain barrier after FUS thalamotomy according to contrast-enhanced MRI. Burdenko's Journal of Neurosurgery. 2025;(4):51-60

Change of speech disorders during bilateral deep stimulation of the subthalamic nucleus of the brain in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):59-65

Oxidative stress and depression in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):131-138

Abstract:

Palliative care is traditionally associated with cancer and pain relief: however, the range of diseases requiring palliative care is much wider and includes many neurodegenerative diseases (Alzheimer’s disease and Parkinson’s disease (PD)). Provision of palliative care to patients with PD and other neurodegenerative diseases, such as multisystem atrophy, progressive supranuclear palsy, dementia with Lewy bodies, etc. is «terra incognita» for many neurologists who are not acknowledged with palliative medicine as well as for specialists in palliative medicine, who are mainly trained in providing care to patients with oncological profile and do not know the intricacies of managing patients in the late stages of PD and other neurodegenerative diseases. The aim of the article is to systematize modern knowledge in the field of palliative medicine and neurodegenerative diseases.

Keywords:

Parkinson’s disease

neurodegenerative diseases

multisystem atrophy

dysphagia

gastrostomy

palliative care

Authors:

Levin O.S.

Russian Medical Academy of Continuous Professional Education

SPIN RSCI: 5342-1373
Scopus AuthorID: 57147160800
ORCID: 0000-0003-3872-5923

Bril E.V.

Burnazyan Federal Medical and Biophysical Center

ORCID: 0000-0002-6524-4490

Zimnyakova O.S.

Burnazyan Federal Medical and Biophysical Center

ORCID: 0000-0001-6501-8541

Anikina M.A.

Burnazyan Federal Medical and Biophysical Center

Hasina A.V.

Burnazyan Federal Medical and Biophysical Center

Fedorova N.V.

Russian Medical Academy of Continuous Professional Education

Received:

15.06.2020

Accepted:

09.09.2020

Close metadata

References:

Russian Statistical Yearbook. 2018. P76. M. 2018;694. (In Russ.).
Anneser J, Arenz V, G. Domenico Borasio. Neurological Symptoms in Palliative Care Patients. Front Neurol. 2018;9:275. https://doi.org/10.3389/fneur.2018.00275
Chahine LM, Malik B, Davis M. Palliative care needs of patients with neurologic or neurosurgical conditions. Eur J Neurol. 2008;15(12):1265-1272. https://doi.org/10.1111/j.1468-1331.2008.02319.x
Liu Y, Kline D, Aerts S, Youngwerth JM, Kutner JS, Sillau S, Kluger BM. Inpatient Palliative Care for Neurological Disorders: Lessons from a Large Retrospective Series. J Palliat Med. 2017;20(1):59-64. https://doi.org/10.1089/jpm.2016.0240
Moens K, Houttekier D, Van den Block L. Place of death of people living with Parkinson’s disease: a population-level study in 11 countries. BMC Palliat Care. 2015;14:28. Published 2015 May 20. https://doi.org/10.1186/s12904-015-0021-3
Maxwell R, Ho D, Hounsome L, Verne J. Deaths from Neurodegenerative Diseases in England, 2002 to 2008. National End of Life Care Intelligence Network Publication date: June 2010.
Gomes B, Calanzani N, Gysels M, Hall S, Higginson I. Heterogeneity and changes in preferences for dying at home: a systematic review. BMC Palliative Care. 2013;12(7):1-13. https://doi.org/10.1186/1472-684X-12-7
Hand A, Gray WK, Oates LL. Medication use in people with late stage Parkinson’s disease and parkinsonism living at home and in institutional care in north-east England: A balance of symptoms and side-effects? Parkinsonism Relat Disord. 2016;32:120-123. https://doi.org/10.1016/j.parkreldis.2016.09.001
Sepúlveda C, Marlin A, Yoshida T, Ullrich A. Palliative Care: the World Health Organization’s global perspective. J Pain Symptom Manage. 2002;24(2):91-96. https://doi.org/10.1016/s0885-3924(02)00440-2
Boersma I, Miyasaki J, Kutner J, Kluger B. Palliative care and neurology: time for a paradigm shift. Neurology. 2014;83(6):561-567. https://doi.org/10.1212/WNL.0000000000000674
Finn L, Malhotra S. The Development of Pathways in Palliative Medicine: Definition, Models, Cost and Quality Impact. Healthcare (Basel). 2019;7(1):22. Published 2019 Feb 1. https://doi.org/10.3390/healthcare7010022
Walker RW, Churm D, Dewhurst F, Samuel M, Ramsell A, Lawrie C. Palliative care in people with idiopathic Parkinson’s disease who died in hospital. BMJ Support Palliat Care. 2014;4(1):64-67. https://doi.org/10.1136/bmjspcare-2012-000412
Lee MA, Prentice WM, Hildreth AJ, Walker RW. Measuring symptom load in Idiopathic Parkinson’s disease. Parkinsonism Relat Disord. 2007;13(5):284-289. https://doi.org/10.1016/j.parkreldis.2006.11.009
Goy ER, Carter JH, Ganzini L Parkinson disease at the end of life: caregi-ver perspectives. Neurology. 2007;69(6):611-612. https://doi.org/10.1212/01.wnl.0000266665.82754.61
Lunney JR, Lynn J, Foley DJ. Patterns of functional decline at the end of life. JAMA. 2003;289:2387-2392. https://doi.org/10.1001/jama.289.18.2387
Murray SA, Kendall M, Boyd K, Sheikh A. Illness trajectories and palliative care. BMJ. 2005;330(7498):1007-1011. https://doi.org/10.1136/bmj.330.7498.1007
Amblàs-Novellas J, Murray SA, Espaulella J. Identifying patients with advanced chronic conditions for a progressive palliative care approach: a cross-sectional study of prognostic indicators related to end-of-life trajectories. BMJ Open. 2016;6(9):e012340. Published 2016 Sep 19. https://doi.org/10.1007/s00228-007-0427-9
Oliver D, Borasio GD, Caraceni A, de Visser M, Grisold W, Lorenzl S, Veronese S, Voltz R. A consensus review on the development of palliative care for patients with chronic and progressive neurological disease Eur J Neurol. 2016;23(1):30-38. https://doi.org/10.1111/ene.12889
Richfield EW, Jones EJ, Alty JE Palliative care for Parkinson’s disease: a summary of the evidence and future directions. Palliat Med. 2013;27(9):805-810. https://doi.org/10.1177/0269216313495287
Walter H., Seeber AA, Willems DL, de Visser M. The Role of Palliative Care in Chronic Progressive Neurological Diseases - A Survey Amongst Neuro-logists in the Netherlands Front Neurol. 2019;9:1157. https://doi.org/10.3389/fneur.2018.01157
Campbell CW, Jones CW, Merrills J, Hull Royal. Palliative and end-of-life care in advanced Parkinson’s disease and multiple sclerosis. Clinical Medicine. 2010;10:3:290-292. https://doi.org/10.7861/clinmedicine.10-3-290
Heyland DK, Barwich D, Pichora D, Dodek P, Lamontagne F, You JJ, Tayler C, Porterfield P, Sinuff T, Simon J, ACCEPT (Advance Care Planning Evaluation in Elderly Patients) Study Team., Canadian Researchers at the End of Life Network (CARENET). Failure to engage hospitalized elderly patients and their families in advance care planning. JAMA Intern Med. 2013;173(9):778-787.
The Irish Palliative Care in Parkinson’s Disease Group. Palliative care in People with Parkinson’s disease: Guidelines for professional healthcare workers on the assessment and management of palliative care needs in Parkinson’s disease and related Parkinsonian syndromes. Cork: University College Cork. 2016.
Levin OS. Phenomenology and treatment of acute decompensation of Parkinson’s disease. Neurologycheskiy journal. 2007;1:8-5. (In Russ.).
Kluger BM, Fox S, Timmons S. Palliative care and Parkinson’s disease: Meeting summary and recommendations for clinical research. Parkinsonism Relat Disord. 2017;37:19-26. https://doi.org/10.1016/j.parkreldis.2017.01.008
Saleem TZ, Higginson IJ, Chaudhuri KR, Martin A, Burman R, Leigh PN. Symptom prevalence, severity and palliative care needs assessment using the Palliative Outcome Scale: a cross-sectional study of patients with Parkinson’s disease and related neurological conditions. Palliat Med. 2013;27(8):722-731. https://doi.org/10.1177/0269216312465783
Miyasaki JM, Long J, Mancini D. Palliative care for advanced Parkinson disease: an interdisciplinary clinic and new scale, the ESAS-PD. Parkinsonism Relat Disord. 2012;18(suppl 3):6-9. https://doi.org/10.1016/j.parkreldis.2012.06.013
Hoehn MM, Yahr. Parkinsonism: onset, progression, and mortality. Neurology. 1967;17(5):427-442.
Levin OS, Fedorova NV. Parkinsons disease. 2 izd. M.: Med-press-inform; 2012. (In Russ.).
Guidelines for the diagnosis and treatment of Parkinson’s disease. Pod redakciey Illarioshkina S.N., Levina O.S. M.: OO «IPK Pareto-Print»; 2017. (In Russ.).
Bril EV, Fedorova NV, Tomskiy AA, Gamaleya AA, Omarova SM, Kesarev DG. Problem of rehabilitation patient with parkinsons disease. Rehabilitation patient with neurostimulation. Farmateka. 2019;26:3:7-13. (In Russ.).
Schuepbach WM, Rau J, Knudsen K. Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med. 2013;368(7):610-622. https://doi.org/10.1056/NEJMoa1205158
Kalf JG, de Swart BJ, Bloem BR, Munneke M. Prevalence of oropharyngeal dysphagia in Parkinson’s disease: a meta-analysis. Parkinsonism Relat Disord. 2012;18(4):311-315. https://doi.org/10.1016/j.parkreldis.2011.11.006
Han M, Ohnishi H, Nonaka M. Relationship between dysphagia and depressive states in patients with Parkinson’s disease. Parkinsonism Relat Disord. 2011;17(6):437-439. https://doi.org/10.1016/j.parkreldis.2011.03.006
Mahler L, Ramig LO, Logemann J, Halpern A. Description of subjective and objective swallow characteristics for people with PD. Poster session presented at: the International Movement Disorders Society; June 26, 2008; Chicago, IL.
Müller J, Wenning GK, Verny M. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol. 2001;58(2):259-264. https://doi.org/10.1001/archneur.58.2.259
Umemoto G, Furuya H. Management of Dysphagia in Patients with Parkinson’s Disease and Related Disorders. Intern Med. 2019. https://doi.org/10.2169/internalmedicine.2373-18
Wood LD, Neumiller JJ, Setter SM, Dobbins EK. Clinical review of treatment options for select nonmotor symptoms of Parkinson’s disease. Am J Geriatr Pharmacother. 2010;8(4):294-315. https://doi.org/10.1016/j.amjopharm.2010.08.002
Lethbridge L, Johnston GM, Turnbull G. Co-morbidities of persons dying of Parkinson’s disease. Prog Palliat Care. 2013;21(3):140-145. https://doi.org/10.1179/1743291X12Y.0000000037
Diagnosis and treatment of dysphagia in diseases of the central nervous system. Clinical guidelines. M. 2013. (In Russ.). https://rehabrus.ru/klinicheskie-rekomendaczii.html
Suttrup I, Warnecke T. Dysphagia in Parkinson’s Disease. Dysphagia. 2016;31(1):24-32. https://doi.org/10.1007/s00455-015-9671-9
Lam K, Lam FK, Lau KK. Simple clinical tests may predict severe oropharyngeal dysphagia in Parkinson’s disease. Mov Disord. 2007;22(5):640-644. https://doi.org/10.1002/mds.21362
Cereda E, Cilia R, Klersy C. Swallowing disturbances in Parkinson’s disease: a multivariate analysis of contributing factors. Parkinsonism Relat Disord. 2014;20(12):1382-1387. https://doi.org/10.1016/j.parkreldis.2014.09.031
Belo LR, Gomes NA, Coriolano M. The relationship between limit of Dysphagia and average volume per swallow in patients with Parkinson’s disease. Dysphagia. 2014;29(4):419-424. https://doi.org/10.1007/s00455-013-9512-7
Kanna SV, Bhanu K. A simple bedside test to assess the swallowing dysfunction in Parkinson’s disease. Ann Indian Acad Neurol. 2014;17(1):62-65. https://doi.org/10.4103/0972-2327.128556
Burgos R, Bretón I, Cereda E. ESPEN guideline clinical nutrition in neurology. Clin Nutr. 2018;37(1):354-396. https://doi.org/10.1016/j.clnu.2017.09.003
Löser C, Aschl G, Hébuterne X. ESPEN guidelines on artificial enteral nutrition — percutaneous endoscopic gastrostomy (PEG). Clin Nutr. 2005;24(5):848-861. https://doi.org/10.1016/j.clnu.2005.06.013
Luchesi KF, Satoshi Kitamura, Lucia Figueiredo Mourão. Management of dysphagia in Parkinson’s disease and amyotrophic lateral sclerosis Article in CoDAS. 2013. https://doi.org/10.1590/S2317-17822013000400010
Tjaden K. Speech and Swallowing in Parkinson’s Disease. Top Geriatr Rehabil. 2008;24(2):115-126. https://doi.org/10.1097/01.TGR.0000318899.87690.44
Byeon H. Effect of simultaneous application of postural techniques and expiratory muscle strength training on the enhancement of the swallowing function of patients with dysphagia caused by parkinson’s disease. J Phys Ther Sci. 2016;28(6):1840-1843. https://doi.org/10.1589/jpts.28.1840
Logemann JA, Gensler G, Robbins J. A randomized study of three interventions for aspiration of thin liquids in patients with dementia or Parkinson’s disease. J Speech Lang Hear Res. 2008;51(1):173-183. https://doi.org/10.1044/1092-4388(2008/013)
Barichella M, Cereda E, Pezzoli G. Major nutritional issues in the management of Parkinson’s disease. Mov Disord. 2009;24(13):1881-1892. https://doi.org/10.1002/mds.22705
Sheard JM, Ash S, Mellick GD, Silburn PA, Kerr GK. Malnutrition in a sample of community-dwelling people with Parkinson’s disease. PLoS One. 2013;8(1):e53290. https://doi.org/10.1371/journal.pone.0053290
Shen L, Ji HF. Associations between Vitamin D Status, Supplementation, Outdoor Work and Risk of Parkinson’s Disease: A Meta-Analysis Assessment. Nutrients. 2015;7(6):4817-4827. Published 2015 Jun 15. https://doi.org/10.3390/nu7064817
Rimmelzwaan LM, van Schoor NM, Lips P, Berendse HW, Eekhoff EM. Systematic Review of the Relationship between Vitamin D and Parkinson’s Disease. J Parkinsons Dis. 2016;6(1):29-37. https://doi.org/10.3233/JPD-150615
Hu XW, Qin SM, Li D, Hu LF, Liu CF. Elevated homocysteine levels in levodopa-treated idiopathic Parkinson’s disease: a meta-analysis. Acta Neurol Scand. 2013;128(2):73-82. https://doi.org/10.1111/ane.12106
Zoccolella S, Lamberti P, Armenise E. Plasma homocysteine levels in Parkinson’s disease: role of antiparkinsonian medications. Parkinsonism Relat Disord. 2005;11(2):131-133. https://doi.org/10.1016/j.parkreldis.2004.07.008
Triantafyllou NI, Kararizou E, Angelopoulos E. The influence of levodopa and the COMT inhibitor on serum vitamin B12 and folate levels in Parkinson’s disease patients. Eur Neurol. 2007;58(2):96-99. https://doi.org/10.1159/000103644
Lamberti P, Zoccolella S, Armenise E. Hyperhomocysteinemia in L-dopa treated Parkinson’s disease patients: effect of cobalamin and folate administration. Eur J Neurol. 2005;12(5):365-368. https://doi.org/10.1111/j.1468-1331.2004.00973.x
Postuma RB, Espay AJ, Zadikoff C. Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: a randomized controlled study. Neurology. 2006;66(12):1941-1943. https://doi.org/10.1212/01.wnl.0000219815.83681.f7
Laudisio A, Vetrano DL, Meloni E. Dopaminergic agents and nutritional status in Parkinson’s disease. Mov Disord. 2014;29(12):1543-1547. https://doi.org/10.1002/mds.25991
Jaafar AF, Gray WK, Porter B, Turnbull EJ, Walker RW. A cross-sectional study of the nutritional status of community-dwelling people with idiopathic Parkinson’s disease. BMC Neurol. 2010;10:124. Published 2010 Dec 30. https://doi.org/10.1186/1471-2377-10-124
Barichella M, Villa MC, Massarotto A. Mini Nutritional Assessment in patients with Parkinson’s disease: correlation between worsening of the malnutrition and increasing number of disease-years. Nutr Neurosci. 2008;11(3):128-134. https://doi.org/10.1179/147683008X301441
Sheard JM, Ash S, Silburn PA, Kerr GK. Prevalence of malnutrition in Parkinson’s disease: a systematic review. Nutr Rev. 2011;69(9):520-532. https://doi.org/10.1111/j.1753-4887.2011.00413.x
Ma K, Xiong N, Shen Y. Weight Loss and Malnutrition in Patients with Parkinson’s Disease: Current Knowledge and Future Prospects. Front Aging Neurosci. 2018;10:1. Published 2018 Jan 19. https://doi.org/10.3389/fnagi.2018.00001
van Asselt DZ, van Bokhorst-de van der Schueren MA, van der Cammen TJ. Assessment and treatment of malnutrition in Dutch geriatric practice: consensus through a modified Delphi study. Age Ageing. 2012;41(3):399-404. https://doi.org/10.1093/ageing/afs005
Sarkar P, Cole A, Scolding NJ, Rice CM. Percutaneous Endoscopic Gastrostomy Tube Insertion in Neurodegenerative Disease: A Retrospective Study and Literature Review. Clin Endosc. 2017;50(3):270-278. https://doi.org/10.5946/ce.2016.106
Murphy LM, Lipman TO. Percutaneous endoscopic gastrostomy does not prolong survival in patients with dementia [published correction appears in Arch Intern Med. 2003;163(19):2397. Arch Intern Med. 2003;163(11):1351-1353. https://doi.org/10.1001/archinte.163.11.1351
Stroud M, Duncan H, Nightingale J; British Society of Gastroenterology. Guidelines for enteral feeding in adult hospital patients. Gut. 2003;52(suppl 7(Suppl 7):1-12. https://doi.org/10.1136/gut.52.suppl_7.vii1
Farber NJ, Urban SY, Collier VU. The good news about giving bad news to patients. J Gen Intern Med. 2002;17(12):914-922. https://doi.org/10.1046/j.1525-1497.2002.20420.x
Lennaerts H, Steppe M, Munneke M. Palliative care for persons with Parkinson’s disease: a qualitative study on the experiences of health care professionals. BMC Palliat Care. 2019;18(1):53. Published 2019 Jul 9. https://doi.org/10.1186/s12904-019-0441-6
Werner A, Steihaug S. Conveying hope in consultations with patients with life-threatening diseases: the balance between supporting and challenging the patient. Scand J Prim Health Care. 2017;35(2):143-152. https://doi.org/10.1080/02813432.2017.1333322
Storstein A. Communication and neurology — bad news and how to break them. Acta Neurol Scand Suppl. 2011;191:5-11. https://doi.org/10.1111/j.1600-0404.2011.01550.x
Kurtz SM. Doctor-Patient Communication: Principles and Practices. Can J Neurol Sci. 2002;29(suppl 2):23-29.
Baile WF, Buckman R, Lenzi R, Glober G, Beale EA, Kudelka AP. SPIKES-A six-step protocol for delivering bad news: application to the patient with cancer. Oncologist. 2000;5(4):302-311. https://doi.org/10.1634/theoncologist.5-4-302
Seeber AA, Pols AJ, Hijdra A, Grupstra HF, Willems DL, de Visser M. Experiences and reflections of patients with motor neuron disease on breaking the news in a two-tiered appointment: a qualitative study. BMJ Support Palliat Care. 2019;9(1):e8. https://doi.org/10.1136/bmjspcare-2015-000977
Strupp J, Kunde A, Galushko M, Voltz R, Golla H. Severely Affected by Parkinson Disease: The Patient’s View and Implications for Palliative Care American Journal of Hospice & Palliative Medicine 1-7 The Author(s). 2017. https://doi.org/10.1177/1049909117722006